Send to a Friend Font Size: Increase Decrease

NTRA and EXEL Related Headlines

Jan 7, 2026 08:02AM Exelixis and Natera partner on phase 3 colorectal cancer trial
Jan 7, 2026 08:00AM Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer

NTRA and EXEL Related Press Releases

Jan 7, 2026 08:00AM Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer

NTRA and EXEL Related SEC Filings